New screening guidelines for the prevention and early detection of cervical cancer are now largely based on the patient’s age, and testing for HPV DNA has now been incorporated into the screening process.
New screening guidelines for the prevention and early detection of cervical cancer are now largely based on the patient’s age, and testing for HPV DNA has now been incorporated into the screening process. The new recommendations are:
No screening before the age of 21.
Pap every 3 years from age 21 – 29, but no HPV screening.
Pap and HPV testing every 5 years from age 30 – 65.
Benefits to these new guidelines include: more time spent discussing BSE, referral for mammography, healthy diet and exercise, risky behaviors, family planning, menopausal transition, osteoporosis prevention, colorectal cancer screening, and evaluation of continence and pelvic floor functioning.
If you follow the new guidelines, will you encourage your patients to come in every year to discuss other health issues? We want to know, add your opinion to the comment box!
Dostarlimab shows significant survival benefits in endometrial cancer trial
March 21st 2024GlaxoSmithKline's phase 3 trial demonstrated promising overall and progression-free survival outcomes in patients with primary advanced or recurrent endometrial cancer, paving the way for potential FDA approval.
Read More
Unifying radical hysterectomy classifications with the Querleu-Morrow
February 16th 2024Explore how the latest research underscores the efficacy of the 2017 Querleu-Morrow classification in defining radical hysterectomy extent, shedding light on surgical terminologies for cervical cancer management.
Read More